Rapid selection of mesenchymal stem and progenitor cells in primary prostate stromal cultures

被引:25
作者
Brennen, W. Nathaniel [1 ]
Kisteman, L. Nelleke [1 ]
Isaacs, John T. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Oncol,Prostate Canc Program, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, 1650 Orleans St,CRB 1,Rm 1M87, Baltimore, MD 21287 USA
关键词
mesenchymal stem cell; MSC; carcinoma-associated fibroblast (CAF); stromal progenitor; normal prostate; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CARCINOMA-ASSOCIATED FIBROBLASTS; SMOOTH-MUSCLE CELLS; MYOFIBROBLASTS CONTRIBUTE; REACTIVE STROMA; DOWN-REGULATION; DIFFERENTIATION; CANCER; PROLIFERATION; EXPRESSION;
D O I
10.1002/pros.23145
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUNDCarcinoma-associated fibroblasts (CAFs) are a dominant component of the tumor microenvironment with pro-tumorigenic properties. Despite this knowledge, their physiologic origins remain poorly understood. Mesenchymal stem cells (MSCs) can be recruited from the bone marrow to areas of tissue damage and inflammation, including prostate cancer. MSCs can generate and have many overlapping properties with CAFs in preclinical models. METHODSMultiparameter flow cytometry and multipotent differentiation assays used to define MSCs in primary prostate stromal cultures derived from young (<25yrs) organ donors and prostate cancer patients compared with bone marrow-derived stromal cultures. Population doubling times, population doublings, cell size, and differentiation potential determined under multiple culture conditions, including normoxia, hypoxia, and a variety of media. TGF- measured by ELISA. RESULTSMSCs and stromal progenitors are not only present in normal and malignant prostate tissue, but are quickly selected for in primary stromal cultures derived from these tissues; becoming the dominant population within just a few passages. Growth potential inversely associated with TGF- concentrations. All conditions generated populations with an average cell diameter >15 mu m. All cultures tested had the ability to undergo osteogenic and chondrogenic differentiation, but unlike bone marrow-derived MSCs, primary stromal cultures derived from normal prostate tissue lack adipogenic differentiation potential. In contrast, a subset of stromal cultures derived from prostate cancer patients retain the ability to differentiate into adipocytes; a property that is significantly suppressed under hypoxic conditions in both bone marrow- and prostate-derived MSCs. CONCLUSIONSPrimary prostate stromal cultures are highly enriched in cells with an MSC or stromal progenitor phenotype. The use of primary cultures such as these to study CAFs raises interesting implications when considering their overlapping properties. The lack of adipogenesis in stromal cultures derived from normal prostates suggests they have a lineage-restricted progenitor phenotype. The retention of adipogenic differentiation in cultures from a subset of prostate cancer patients suggests the active recruitment of less committed progenitors or MSCs from the bone marrow as a function of disease progression. This recruitment can potentially be exploited for prognostic purposes or a cell-based platform for the systemic delivery of cytotoxic agents to sites of prostate cancer. Prostate 76:552-564, 2016. (c) 2016 Wiley Periodicals, Inc.
引用
收藏
页码:552 / 564
页数:13
相关论文
共 74 条
[1]   Serum-Free Spheroid Suspension Culture Maintains Mesenchymal Stem Cell Proliferation and Differentiation Potential [J].
Alimperti, Stella ;
Lei, Pedro ;
Wen, Yuan ;
Tian, Jun ;
Campbell, Andrew M. ;
Andreadis, Stelios T. .
BIOTECHNOLOGY PROGRESS, 2014, 30 (04) :974-983
[2]   The reactive stroma microenvironment and prostate cancer progression [J].
Barron, David A. ;
Rowley, David R. .
ENDOCRINE-RELATED CANCER, 2012, 19 (06) :R187-R204
[3]   SYNTHESIS AND EXPRESSION OF SMOOTH-MUSCLE PHENOTYPE MARKERS IN PRIMARY CULTURE OF RABBIT AORTIC SMOOTH-MUSCLE CELLS - INFLUENCE OF SEEDING DENSITY AND MEDIA AND RELATION TO CELL CONTRACTILITY [J].
BIRUKOV, KG ;
FRID, MG ;
ROGERS, JD ;
SHIRINSKY, VP ;
KOTELIANSKY, VE ;
CAMPBELL, JH ;
CAMPBELL, GR .
EXPERIMENTAL CELL RESEARCH, 1993, 204 (01) :46-53
[4]   Mesenchymal progenitor cells:: Tissue origin, isolation and culture [J].
Bourin, Philippe ;
Gadelorge, Melanie ;
Peyrafitte, Julie-Anne ;
Fleury-Cappellesso, Sandrine ;
Gomez, Marilyn ;
Rage, Christine ;
Sensebe, Luc .
TRANSFUSION MEDICINE AND HEMOTHERAPY, 2008, 35 (03) :160-167
[5]   Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment [J].
Brennen, W. Nathaniel ;
Denmeade, Samuel R. ;
Isaacs, John T. .
ENDOCRINE-RELATED CANCER, 2013, 20 (05) :R269-R290
[6]   Quantification of Mesenchymal Stem Cells (MSCs) at Sites of Human Prostate Cancer [J].
Brennen, W. Nathaniel ;
Chen, Shuangling ;
Denmeade, Samuel R. ;
Isaacs, John T. .
ONCOTARGET, 2013, 4 (01) :106-117
[7]   Rationale Behind Targeting Fibroblast Activation Protein-Expressing Carcinoma-Associated Fibroblasts as a Novel Chemotherapeutic Strategy [J].
Brennen, W. Nathaniel ;
Isaacs, John T. ;
Denmeade, Samuel R. .
MOLECULAR CANCER THERAPEUTICS, 2012, 11 (02) :257-266
[8]   Why are MSCs therapeutic? New data: new insight [J].
Caplan, Al .
JOURNAL OF PATHOLOGY, 2009, 217 (02) :318-324
[9]   The MSC curtain that stops the immune system [J].
Caplan, Arnold I. ;
Sorrell, J. Michael .
IMMUNOLOGY LETTERS, 2015, 168 (02) :136-139
[10]   Modeling pO2 distributions in the bone marrow hematopoietic compartment.: II.: Modified Kroghian models [J].
Chow, DC ;
Wenning, LA ;
Miller, WM ;
Papoutsakis, ET .
BIOPHYSICAL JOURNAL, 2001, 81 (02) :685-696